CSIMarket
 


Procyon Corporation  (PCYN)
Other Ticker:  
 
 

PCYN's EPS Net Growth by Quarter and Year

Procyon's EPS Net results by quarter and year




PCYN EPS Net (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - 0.00 -0.01 0.05
III Quarter March - 0.00 -0.01 0.00
II Quarter December -0.03 0.00 -0.01 0.01
I Quarter September -0.01 0.00 0.00 0.03
FY   -0.04 0.00 -0.03 0.09



PCYN EPS Net second quarter 2024 Y/Y Growth Comment
Procyon Corporation in the second quarter 2024 recorded EPS net loss of $ -0.03 .

According to the results reported in the second quarter 2024, Procyon Corporation achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Procyon Corporation' s EPS Net no change of % ranks overall at the positon no. in the second quarter 2024.




PCYN EPS Net ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - 200 %
FY   - - - 350 %

Financial Statements
Procyon's second quarter 2024 EPS Net $ -0.03 PCYN's Income Statement
Procyon's second quarter 2023 EPS Net $ 0.00 Quarterly PCYN's Income Statement
New: More PCYN's historic EPS Net Growth >>


PCYN EPS Net (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -66.67 %
I Quarter September - - - -
FY (Year on Year)   - - - 350 %




EPS Net second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Procyon's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PCYN's II. Quarter Q/Q EPS Net Comment
II. Quarter 2024 EPS net loss of -0.03 by Procyon Corporation come out even less good if you take a look at EPS net loss -0.01 a quarter before.

Within Major Pharmaceutical Preparations industry Procyon Corporation achieved highest sequential EPS Net growth. While Procyon's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PCYN's II. Quarter Q/Q EPS Net Comment
II. Quarter 2024 EPS net loss of -0.03 by Procyon Corporation look even less good compare to the -0.01 EPS net loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Procyon Corporation achieved highest sequential EPS Net growth. While Procyon's EPS Net growth quarter on quarter, overall rank is .


Procyon's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS Net 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
In the Dec 31 2023 period, Procyon's cumulative trailing twelve month EPS Net remained unchanged compare to the same period a year ago.

Procyon Corporation achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
In the Dec 31 2023 period, Procyon's cumulative trailing twelve month EPS Net remained unchanged compare to the same period a year ago.

Procyon Corporation achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
PCYN's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for PCYN's Competitors
EPS Net Growth for Procyon's Suppliers
EPS Net Growth for PCYN's Customers

You may also want to know
PCYN's Annual Growth Rates PCYN's Profitability Ratios PCYN's Asset Turnover Ratio PCYN's Dividend Growth
PCYN's Roe PCYN's Valuation Ratios PCYN's Financial Strength Ratios PCYN's Dividend Payout Ratio
PCYN's Roa PCYN's Inventory Turnover Ratio PCYN's Growth Rates PCYN's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2023
Charles River Laboratories International inc -1.31%$ -1.311 
Encompass Health Corporation-3.73%$ -3.731 
Regeneron Pharmaceuticals Inc -4.07%$ -4.066 
Haemonetics Corporation-4.69%$ -4.688 
Edwards Lifesciences Corporation-5.96%$ -5.957 
Resmed Inc -7.19%$ -7.190 
Bristol myers Squibb Company-8.78%$ -8.778 
Avenue Therapeutics Inc -11.55%$ -11.547 
Gilead Sciences Inc -11.97%$ -11.969 
Utah Medical Products Inc-14.08%$ -14.084 
Masimo Corp-18.55%$ -18.550 
Merit Medical Systems Inc-18.93%$ -18.927 
Qiagen N v -19.57%$ -19.565 
Avantor Inc -22.62%$ -22.616 
Fresenius Medical Care Ag-26.09%$ -26.087 
Mettler toledo International Inc -28.51%$ -28.506 
Star Equity Holdings Inc -29.22%$ -29.218 
Harmony Biosciences Holdings inc -38.72%$ -38.717 
Amedisys Inc -39.32%$ -39.315 
Avanos Medical Inc -39.47%$ -39.469 
Pro dex Inc -41.67%$ -41.667 
Embecta Corp -42.62%$ -42.623 
Becton Dickinson And Company-43.53%$ -43.529 
Bio techne Corp-45.16%$ -45.161 
Amgen Inc -52.98%$ -52.977 
Biogen Inc -55.59%$ -55.590 
Taro Pharmaceutical Industries Ltd-56.13%$ -56.129 
Bio rad Laboratories Inc -56.74%$ -56.736 
Integra Lifesciences Holdings Corp-60.46%$ -60.461 
Henry Schein Inc-60.47%$ -60.467 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com